MedTech (NASDAQ:MTAC) terminated its combination with surgical technology company Memic this morning after adjourning it’s scheduled meeting to complete yesterday to this morning at 11AM.
Yesterday’s meeting received sufficient turnout and affirmative votes, but adjourned without finalizing any business. A number of SPAC deals have fallen through in the current climate of high redemptions and while MedTech did not disclose redemption figures, they were likely the cause of the breakup.
The parties’ combination agreement required MedTech to maintain at least $250 million in cash available and that less than 50% of its trust be redeemed by shareholders. Only five of the 30 votes reported by SPACs so far this year have seen redemptions under 50% and that includes extension votes, which typically see lower figures.
Nonetheless, more optimistic deal terms were not unreasonable when the $655 million combination was announced on August 13, 2021. MedTech also supplemented the transaction with a $76 million PIPE, but adding to PIPEs has become increasingly difficult in the present environment.
MedTech will continue to seek out a combination and has time with transaction deadline set for December 22, 2022.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...